spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  medical aesthetics 

 HSMN NewsFeed - 22 Nov 2022
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
Devices Dermatology FDA
 HSMN NewsFeed - 6 Oct 2022
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
Devices Dermatology FDA
 HSMN NewsFeed - 8 Jul 2022
LASEROPTEK Co. Ltd., and Monarch Lasers Sign a Multi-Year Exclusive Distribution Agreement for the United States Medical Aesthetic Market
Devices Dermatology Distribution
 HSMN NewsFeed - 1 Dec 2021
Cutera Launches Next Gen Rapid Muscle Sculpting with truSculpt(R) flex+
Devices Product Launch
 HSMN NewsFeed - 16 Nov 2021
Sofwave(TM) Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental (beneath the chin) and Neck Facial Areas
Devices Dermatology FDA
 HSMN NewsFeed - 5 Oct 2021
GC Aesthetics(R) Achieves Compelling Surgical And Patient Care Results With FixNip NRI(TM), The Revolutionary Nipple Reconstruction Device
Devices Surgery
 HSMN NewsFeed - 25 May 2021
GC Aesthetics(R) Launches Next Generation Of Breast Implants
Devices Surgery Product Launch
 HSMN NewsFeed - 8 Apr 2021
Crown Aesthetics Proudly Announces New Indication For Treatment Of Neck Wrinkles For FDA-Cleared Microneedling System, SkinPen(R) Precision
Devices Dermatology FDA
 HSMN NewsFeed - 8 Mar 2021
Solta Medical Announces the U.S. Launch of The Clear + Brilliant(R) Touch Laser
Devices Dermatology Product Launch
 HSMN NewsFeed - 4 Nov 2020
Lutronic Introduces Intelligent Care in Muscle Stimulation with IntelliSTIM(TM) - A Third Generation Body Sculpting Device
Devices Product Launch
 HSMN NewsFeed - 14 Sep 2020
CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
Devices Regenerative Medicine Wound Care Distribution
 HSMN NewsFeed - 27 Aug 2020
Healeon Announces FDA 510(k) Clearance for Duet Office-Based Blood Separation and Concentration System
Devices FDA
 HSMN NewsFeed - 29 Apr 2020
Bimini Health Tech Announces FDA 510(k) Clearance for Dermapose Access Office-Based Fat Harvesting System
Devices Dermatology FDA
 HSMN NewsFeed - 22 Apr 2020
Bimini Health Tech Announces FDA 510(k) Clearance for Dermapose Refresh Fat Transfer Technology
Devices Dermatology FDA Product Launch
 HSMN NewsFeed - 11 Mar 2020
INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific
Devices Personnel
 HSMN NewsFeed - 10 Feb 2020
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 30 Jan 2020
Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 24 Jan 2020
Crown Aesthetics Announces Addition Of ProGen PRP(TM) Advantage To ProGen PRP Portfolio
Devices Dermatology Product Launch
 HSMN NewsFeed - 17 Jan 2020
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 21 Nov 2019
Silk Medical Aesthetics Completes Enrollment in Clinical Trial for Industry's First Silk-Based Dermal Filler
Devices Dermatology
 HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 11 Nov 2019
Allergan Receives FDA Qualified Infectious Disease Product (QIDP) Designation And Fast Track Designation For ATM-AVI (Aztreonam And Avibactam) For Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Oct 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Sep 2019
CollPlant Biotechnologies Closes on $5.5 Million Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA
 HSMN NewsFeed - 30 Aug 2019
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Aug 2019
CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue
Regenerative Medicine
 HSMN NewsFeed - 24 Jul 2019
Allergan Voluntarily Recalls BIOCELL(R) Textured Breast Implants and Tissue Expanders
Devices Product Recall
 HSMN NewsFeed - 17 Jul 2019
U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 25 Jun 2019
AbbVie to Acquire Allergan in Transformative Move for Both Companies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jun 2019
Allergan Receives FDA Clearance For CoolTone(TM) Device
Devices Dermatology FDA
 HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jun 2019
CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business
Regenerative Medicine Wound Care
 HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2019
Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks
Regenerative Medicine Wound Care
 HSMN NewsFeed - 7 Mar 2019
FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2018
Allergan Makes New Appointments to Finance Leadership Team
Biopharmaceuticals Ophthalmology Dermatology Personnel
 HSMN NewsFeed - 16 Oct 2018
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 4 Oct 2018
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
Devices Dermatology FDA
 HSMN NewsFeed - 14 Sep 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 8 Aug 2018
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
Biopharmaceuticals Ophthalmology Dermatology Personnel
 HSMN NewsFeed - 23 Jul 2018
Allergan Receives FDA Fast Track Designation for AGN-241751 for the Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jun 2018
Allergan Continues Active Board Refreshment Process
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2018
Cytrellis Biosystems Completes $28.5 Million Series B Financing
Devices Dermatology Venture Capital Personnel
 HSMN NewsFeed - 23 Mar 2018
Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin(R)) For The Treatment Of Three Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2017
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2017
Allergan Receives FDA Clearance For the CoolSculpting(R) Treatment To Improve Appearance Of Lax Tissue In The Double Chin
Devices Dermatology FDA
 HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Oct 2017
Sientra Supports Reconstructive Breast Patients with Launch of Full Circle(TM) Grant Program and Revolutionary Portfolio of Tissue Expanders
Devices Oncology Product Launch
 HSMN NewsFeed - 4 Oct 2017
Solta Medical Receives FDA 510(k) Clearance for Thermage FLX(TM) System, Newest Generation Skin Smoothing Technology
Devices Dermatology FDA
 HSMN NewsFeed - 25 Sep 2017
Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2017
Recros Medica Appoints Thomas A. Albright as President and CEO
Devices Dermatology Personnel
 HSMN NewsFeed - 7 Aug 2017
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 31 Jul 2017
Amgen and Allergan Submit Biosimilar Biologics License Application for ABP 980 to US Food and Drug Administration
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 15 Jun 2017
Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure(R) for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs
Devices FDA
 HSMN NewsFeed - 28 Apr 2017
Allergan Successfully Completes ZELTIQ(R) Aesthetics Acquisition
Devices Mergers & Acquisitions
 HSMN NewsFeed - 27 Apr 2017
Allergan Announces Advisory Role for Breast Implant Pioneer Hani Zeini
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 18 Apr 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 22 Mar 2017
Allergan Announces Availability of RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 20 Mar 2017
JUVÉDERM VOLLURE(TM) XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21
Devices Dermatology FDA
 HSMN NewsFeed - 17 Jan 2017
Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2016
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 Nov 2016
Cynosure Receives CFDA Clearance to Market the Icon(TM) Aesthetic System in China
Devices Dermatology Regulatory
 HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Devices Ophthalmology FDA
 HSMN NewsFeed - 10 Nov 2016
Allergan Announces Launch of TAYTULLA(TM) (Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules) 1 mg/20 mcg, the First and Only Oral Contraceptive Softgel Capsule
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 28 Oct 2016
Allergan Introduces RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05%, a New Delivery System for the One and Only FDA Approved Treatment to Help Patients Produce More of Their Own Tears
Biopharmaceuticals Ophthalmology FDA Product Launch
 HSMN NewsFeed - 25 Oct 2016
Allergan Successfully Completes Vitae Tender Offer
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 17 Oct 2016
Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2016
Allergan plc Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to MEDI2070 Inflammatory Disorder Development Program
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 20 Sep 2016
Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH
Biopharmaceuticals Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Biopharmaceuticals Distribution Acquisitions
 HSMN NewsFeed - 23 Jun 2016
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ(R) (ceftazidime and avibactam)
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 May 2016
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Devices Ophthalmology
 HSMN NewsFeed - 9 May 2016
Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals
 HSMN NewsFeed - 2 May 2016
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 29 Apr 2016
Allergan Receives CHMP Positive Opinion For ENZEPI(R) (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Apr 2016
Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Mar 2016
Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex(R) 1200mg ER Tablets
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 17 Mar 2016
Allergan Confirms Generic Abraxane(R) Patent Challenge
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Mar 2016
Allergan Announces U.S. Availability of VRAYLAR(TM) (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 10 Mar 2016
Allergan Receives Complete Response Letter from FDA for Prior Approval Supplement for RESTASIS(R) (Cyclosporine Ophthalmic Emulsion) 0.05% Multi-Dose Preservative-Free Bottle
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 2 Mar 2016
Envy Medical, Inc. Appoints Arash A. Khazei As Chief Executive Officer
Devices Dermatology Personnel
 HSMN NewsFeed - 29 Feb 2016
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
Biopharmaceuticals Generics Gastroenterology FDA
 HSMN NewsFeed - 24 Feb 2016
FDA Accepts and Grants Priority Review for AVYCAZ(R) (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jan 2016
Allergan Announces Collaboration with AstraZeneca to Develop and Commercialize ATM-AVI (aztreonam and avibactam) for Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 29 Jan 2016
Allergan's Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 14 Dec 2015
Allergan Announces U.S. Availability of VIBERZI(TM) (eluxadoline) for Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 23 Nov 2015
Pfizer and Allergan to Combine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Nov 2015
Allergan Enters Into Licensing Agreement with Mimetogen Pharmaceuticals to Develop and Commercialize Tavilermide (MIM-D3) Topical Dry Eye Treatment
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 4 Nov 2015
Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
Devices Acquisitions
 HSMN NewsFeed - 29 Oct 2015
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 1 Oct 2015
U.S. FDA Approves JUVEDERM(R) ULTRA XC for Use in Lips
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 7 Jul 2015
Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program
Biopharmaceuticals Acquisitions Licensing
 HSMN NewsFeed - 6 Jul 2015
Allergan to Acquire Oculeve Dry Eye Disease Development Programs
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 17 Jun 2015
Allergan to Acquire KYTHERA Biopharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 27 Feb 2015
FDA Approves Allergan’s NATRELLE INSPIRA(TM) Round Gel-Filled Breast Implants
Devices FDA
 HSMN NewsFeed - 10 Nov 2014
BSD Medical Names Medical Device Veteran Clint Carnell President and Chief Executive Officer
Devices Oncology Personnel
 HSMN NewsFeed - 29 Sep 2014
Allergan Announces FDA Approves Revised Indication for OZURDEX(R) (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Drug Delivery FDA
 HSMN NewsFeed - 29 Sep 2014
Allergan Board of Directors Issues Statement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 28 May 2014
Allergan Confirms Receipt of Revised, Unsolicited Proposal from Valeant
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 May 2014
Allergan Board Unanimously Rejects Unsolicited Proposal from Valeant
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 May 2014
BOTOX(R) (Botulinum Toxin Type A) Receives a Positive Opinion in Fourteen European Countries for the Treatment of Focal Spasticity of the Ankle in Adult Post Stroke Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Feb 2014
GC Aesthetics raises $60M to Fund Global Growth and New Product Development
Devices Dermatology Venture Capital
 HSMN NewsFeed - 4 Feb 2014
BOTOX(R) (Botulinum toxin type A) Receives Approval in the UK for the Treatment of Ankle Disability due to Lower Limb Spasticity Associated with Stroke in Adults
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 7 Jan 2014
Allergan, Inc. and Medytox, Inc. Complete Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Dec 2013
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Nov 2013
Solta Medical Secures $40 Million Financing
Devices Dermatology Venture Capital
 HSMN NewsFeed - 23 Oct 2013
FDA Approves JUVÉDERM VOLUMA(TM) XC
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 20 Jun 2013
Fraxel(R) Dual Laser System Receives New FDA 510(k) Clearance For Treatment Of Skin Pigmentation
Devices Dermatology FDA
 HSMN NewsFeed - 12 Jun 2013
Mark Sieczkarek Elected Chairman of the Board of Solta Medical
Devices Dermatology Personnel
 HSMN NewsFeed - 6 May 2013
Solta Medical Announces The Thermage(R) Total Tip
Devices Dermatology
 HSMN NewsFeed - 21 Feb 2013
FDA Approves Natrelle(R) 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
Devices FDA
 HSMN NewsFeed - 23 Jan 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2012
Allergan, Inc. to Acquire SkinMedica, Inc.
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 31 May 2012
Solta Medical Announces Latest Advance in Fraxel(R) Laser Technology
Devices Dermatology
 HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 2 Apr 2012
Solta Medical Introduces Liposonix(R) at AMWC in Monaco and Announces its Portfolio of Aesthetic Energy Devices Reaches Industry Milestone With More Than 2 Million Procedures Completed Globally
Devices
 HSMN NewsFeed - 23 Dec 2011
Allergan Reassures Patients and Surgeons of the Quality and Safety of Its Breast Implant Devices Sold and Distributed Worldwide
Devices
 HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 6 May 2011
Solta Medical Announces FDA 510(k) Clearance for New Clear + Brilliant Technology
Devices Dermatology FDA
 HSMN NewsFeed - 18 Mar 2011
Solta Medical Transitions Leadership Team
Devices Personnel
 HSMN NewsFeed - 31 Aug 2010
Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Jun 2010
Solta Medical Announces Thermage CPT and Fraxel re:store(R) Dual Systems Receive Health Canada Approval
Devices Dermatology Regulatory
 HSMN NewsFeed - 11 May 2010
Solta Medical and Alma Lasers Resolve Patent Lawsuits
Devices Litigation
 HSMN NewsFeed - 15 Apr 2010
Fraxel re:store(R) Dual Laser Proven Effective in Treating Actinic Keratoses, a Common Precancerous Skin Condition
Devices Dermatology
 HSMN NewsFeed - 1 Mar 2010
Solta Medical Completes Acquisition of Aesthera Corporation
Devices Mergers & Acquisitions
 HSMN NewsFeed - 19 Feb 2010
Merz to Complete Acquisition of BioForm Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 4 Jan 2010
Merz to Acquire BioForm Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Nov 2009
Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
Devices Dermatology
 HSMN NewsFeed - 13 Oct 2009
Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
Devices Personnel
 HSMN NewsFeed - 6 Mar 2009
BioForm Medical to Launch New 1.5cc RADIESSE(r) Volume Advantage Syringe and 0.8cc RADIESSE Moderate Fill Syringe; Announces Successful Results of RADIESSE Dermal Filler With Lidocaine Clinical Study
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Jan 2009
Thermage, Inc. Announces Name Change to Solta Medical, Inc.
Devices Dermatology
 HSMN NewsFeed - 8 Jul 2008
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
Devices Dermatology Distribution
 HSMN NewsFeed - 10 Jun 2008
CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
Devices Regulatory
 HSMN NewsFeed - 4 Jun 2008
Allergan Announces Intent to File New Drug Application for Bimatoprost as Novel Treatment to Stimulate Natural Eyelash Growth
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2007
Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Nov 2007
Allergan, Inc. and Covidien Ltd. Enter into Co-Promotion Agreement for LAP-BAND(R) Adjustable Gastric Banding System
Devices
 HSMN NewsFeed - 7 Nov 2007
BioForm Announces Pricing of Initial Public Offering
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 31 Oct 2007
Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 Oct 2007
Allergan Announces Completion of Esprit Pharma Acquisition
Biopharmaceuticals Urology Mergers & Acquisitions
 HSMN NewsFeed - 19 Sep 2007
Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Aug 2007
BioForm Licenses U.S. Rights to Leading European Varicose Vein Treatment
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 3 Jul 2007
BioForm Strengthens Management Team With Three Leading Industry Executives
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 26 Jun 2007
Allergan Announces FDA Approval of Label Extensions for JUVEDERM(TM) Ultra and JUVEDERM(TM) Ultra Plus
Devices Dermatology FDA
 HSMN NewsFeed - 14 May 2007
Syneron Announces Management Change in Support of Company's Long-Term Growth Strategies
Devices Personnel
 HSMN NewsFeed - 12 Apr 2007
U.S. Federal Circuit Court Affirms Judgment for Allergan, Inc. and Roche Palo Alto, LLC against Apotex, Inc., Apotex Corp., and Novex Pharma in Ketorolac Patent Infringement Lawsuit
Biopharmaceuticals Ophthalmology Generics Litigation
 HSMN NewsFeed - 22 Feb 2007
Allergan Announces Its Acquisition of EndoArt, a Leading Swiss Developer of Remote-Controlled Medical Devices
Devices Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2007
Allergan, Inc. Announces Nationwide Availability of JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS Dermal Fillers
Devices
 HSMN NewsFeed - 27 Dec 2006
FDA Approves Radiesse(R) Facial Filler for Two New Aesthetic Indications
Devices Dermatology FDA
 HSMN NewsFeed - 21 Dec 2006
Allergan Announces FDA Issues Approvable Letter for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 4 Dec 2006
Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2006
Allergan Announces FDA Approval of INAMED(R) Silicone-Filled Breast Implants for Breast Augmentation, Reconstruction and Revision Surgery
Devices FDA
 HSMN NewsFeed - 20 Oct 2006
Allergan announces Health Canada grants medical device license to its two silicone-filled breast implant product lines
Devices Regulatory
 HSMN NewsFeed - 5 Oct 2006
Allergan Integrates Inamed's Commercial and Research and Development Operations within New Corporate Division, Allergan Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2006
Allergan, Inc. Announces Launch of JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 18 Sep 2006
FoxHollow Technologies Increases Depth of Management Team With Two Senior Vice Presidents
Devices Interventional Personnel
 HSMN NewsFeed - 23 Jun 2006
Allergan Announces FDA Approval of LUMIGAN(R) as First-Line Treatment for Elevated Eye Pressure in Open-Angle Glaucoma
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 25 May 2006
Allergan Receives Pan European License for GANFORT(R) (LUMIGAN(R)/Timolol Combination) from European Commission
Biopharmaceuticals Ophthalmology Regulatory
Return to NewsFeed  

 Additional items found! 20

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 20 additional stories matching:
medical aesthetics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.